Concepedia

Frederick T. Murphy

FT

22

Publications

2.2K

Citations

20

H-Index

1998

Active since

Affiliations

Altoona Center for Clinical Research(Current)

University of Pennsylvania

Brooke Army Medical Center

University of California San Diego

Medical University of Vienna

Frederick T. Murphy is an author at Altoona Center for Clinical Research specializing in medicine, rheumatology, and rheumatoid arthritis.

Top concepts

Publications per year

1998–2020

22

Publications

22

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial

Josef S Smolen, Jonathan Kay, Mittie K. Doyle et al. · The Lancet · 2009 · 516 citations

, , +11

Treatment of rheumatoid arthritis with a syk kinase inhibitor: A twelve‐week, randomized, placebo‐controlled trial

Michael E. Weinblatt, Arthur Kavanaugh, Rubén Burgos‐Vargas et al. · Arthritis & Rheumatism · 2008 · 334 citations

The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study

Robert Terkeltaub, John S. Sundy, H. Ralph Schumacher et al. · Annals of the Rheumatic Diseases · 2009 · 295 citations · Full text

Tanezumab Reduces Osteoarthritic Knee Pain: Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial

Mark T. Brown, Frederick T. Murphy, David Radin et al. · Journal of Pain · 2012 · 194 citations

, , +7

Tanezumab Reduces Osteoarthritic Hip Pain: Results of a Randomized, Double‐Blind, Placebo‐Controlled Phase III Trial

M. Brown, Frederick T. Murphy, David Radin et al. · Arthritis & Rheumatism · 2013 · 123 citations

Rows per page

1–5 of 22